Phase II trial of topotecan in patients with advanced, persistent, or recurrent uterine leiomyosarcomas: a Gynecologic Oncology Group Study. - Miller,D.S.; Blessing,J.A.; Kilgore,L.C.; Mannel,R.; Van Le,L. (Am J Clin Oncol, 2000)